// STATE LEGISLATION TRACKER

Kentucky HB 910 — AN ACT relating to drug paraphernalia.

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Unknown

State: Kentucky
Bill: HB 910
Filed: 2026-03-04
Read the bill: OpenStates →
Last reviewed: 2026-06-21

Plain-English Summary

Kentucky HB910 is titled as a drug paraphernalia bill, and the available metadata does not show peptide-specific content. Based on the title and subjects only, it does not appear to affect compounded peptides, off-label prescribing, telehealth, NP/naturopath scope, FDA 503A/503B compounding, or prescription monitoring for peptides.

Key Points

No clear peptide access issue is visible from the title or subjects
No indication it changes compounding rules for peptides
No indication it changes telehealth prescribing rules
No indication it changes NP or naturopath scope
Controlled-substance relevance appears limited to paraphernalia, not peptides

What to Watch For

Note Review full bill text if available later to confirm it does not redefine supplies used for legitimate medication use.

Note Track whether later amendments add pharmacy, prescribing, or controlled-substance language.

Where the Bill Stands

The provided source says the latest action refetch failed, so the bill's current position in the Kentucky process is unknown from the available data.

— Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-06-21 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws